Arcus Biosciences Inc (RCUS)
15.49
-0.01
(-0.06%)
USD |
NYSE |
May 02, 16:00
15.49
0.00 (0.00%)
After-Hours: 20:00
Arcus Biosciences Cash from Operations (TTM): -306.00M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -306.00M |
September 30, 2023 | -288.00M |
June 30, 2023 | -306.00M |
March 31, 2023 | -314.00M |
December 31, 2022 | 438.00M |
September 30, 2022 | 446.07M |
June 30, 2022 | 473.31M |
March 31, 2022 | 464.32M |
December 31, 2021 | -256.00M |
September 30, 2021 | -244.12M |
June 30, 2021 | 25.90M |
March 31, 2021 | 75.96M |
December 31, 2020 | 111.00M |
Date | Value |
---|---|
September 30, 2020 | 151.58M |
June 30, 2020 | -92.08M |
March 31, 2020 | -87.90M |
December 31, 2019 | -73.46M |
September 30, 2019 | -71.10M |
June 30, 2019 | -55.46M |
March 31, 2019 | -46.59M |
December 31, 2018 | -43.00M |
September 30, 2018 | -20.30M |
June 30, 2018 | -32.77M |
March 31, 2018 | -28.71M |
December 31, 2017 | -25.06M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-314.00M
Minimum
Mar 2023
473.31M
Maximum
Jun 2022
4.843M
Average
-71.10M
Median
Sep 2019
Cash from Operations (TTM) Benchmarks
Gilead Sciences Inc | 8.481B |
Catalyst Pharmaceuticals Inc | 143.60M |
Integra Lifesciences Holdings Corp | 139.96M |
Palatin Technologies Inc | -26.54M |
Petros Pharmaceuticals Inc | -7.626M |